PAIN
Volume 114, Issue 1 , Pages 221-230 , March 2005

Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain

  • Megumi Shimoyama

      Affiliations

    • Department of Autonomic Physiology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba-ken 260-8670, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 43 226 2030; fax: +81 43 226 2034.
    • ,
  • Hozumi Tatsuoka

      Affiliations

    • Section for Nanotechnology in Neuroscience, Research Center for Frontier Medical Engineering, Chiba University, Chiba, Japan
    • ,
  • Seiji Ohtori

      Affiliations

    • Department of Orthopedic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
    • ,
  • Koichi Tanaka

      Affiliations

    • Department of Anatomy, Hyogo Medical College, Nishinomiya, Japan
    • ,
  • Naohito Shimoyama

      Affiliations

    • Division of Pain Medicine and Palliative Care, National Cancer Center Hospital, Tokyo, Japan

Received 20 October 2004 ,Revised 9 November 2004 ,Accepted 13 December 2004.

References 

  1. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A. Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum. 1995;38:699–709
  2. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107
  3. Bennett GJ, Kajander KC, Sahara Y, Iadarola MJ, Sugimoto T. Neurochemical and anatomical changes in the dorsal horn of rats with an experimental painful peripheral neuropathy. In:  Cervero F,  Bennett GJ editor. Processing of sensory information in the superficial dorsal horn of the spinal cord. New York: Plenum; 1989;p. 463–471
  4. Cain DM, Wacnik PW, Turner M, Wendelschafer-Crabb G, Kennedy WR, Wilcox G, et al. Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci. 2001;21:9367–9376
  5. Catheline G, Le Guen S, Honore P, Besson J-M. Are there long-term changes in the basal or evoked Fos expression in the dorsal horn of the spinal cord of the mononeuropathic rat?. Pain. 1999;80:347–357
  6. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, et al. DREAM is a critical transcriptional repressor for pain modulation. Cell. 2002;108:31–43
  7. Cruz L, Basbaum AI. Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and spinal cord of the cat. J Comp Neurol. 1985;240:331–348
  8. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992;49:693–698
  9. Foley KM. Pain syndromes in patients with cancer. In:  Portenoy RK,  Kanner RM editor. Pain management: theory and practice. Philadelphia, PA: F.A. Davis Company; 1996;p. 191–215
  10. Honore P, Luger NM, Sabino MC, Schwei MJ, Rogers SD, Mach DB, et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med. 2000;6:521–528
  11. Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 2000;98:585–598
  12. Kajander KC, Sahara Y, Iadarola MJ, Bennett GJ. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides. 1990;11:719–728
  13. Kajander KC, Madsen AM, Iadarola MJ, Draisci G, Wakisaka S. Fos-like immunoreactivity increases in the lumber spinal cord following a chronic constriction injury to the sciatic nerve of rat. Neurosci Lett. 1996;206:9–12
  14. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992;50:355–363
  15. Kim SH, Yoon YW, Chung JM. Comparison of three rodent neuropathic pain models. Exp Brain Res. 1997;113:200–206
  16. Laughlin TM, Vanderah TW, Lashbrook JM, Nichols ML, Ossipov MH, Porreca F, et al. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 1997;72:253–260
  17. Malan TP, Ossipov MH, Gardell LR, Ibrahim M, Bian D, Lai J, et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain. 2000;86:185–194
  18. Martin LA, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manage. 1997;14:99–117
  19. Menetrey D, Basbaum AI. The distribution of substance P-, enkephalin- and dynorphin-immunoreactive neurons in the medulla of the rat and their contribution to bulbospinal pathways. Neuroscience. 1987;23:173–187
  20. Moulin DE. Neuropathic cancer pain: syndromes and clinical controversies. In:  Bruera E,  Portenoy RK editor. Topics in palliative care. vol. 2:New York: Oxford University Press; 1998;p. 7–29
  21. Munglani R, Hudspith MJ, Fleming B, Harrisson S, Smith G, Bountra C, et al. Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain. Brain Res. 1999;822:210–219
  22. Nahin RL, Ren K, De Leon M, Ruda M. Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain. 1994;58:95–108
  23. Pereira J. Management of bone pain. In:  Portenoy RK,  Bruera E editor. Topics in palliative care. vol. 3:New York: Oxford University Press; 1998;p. 79–116
  24. Portenoy RK, Forbes K, Lussier D, Hanks G. Difficult pain problems: an integrated approach. In:  Dolye D,  Hanks G,  Cherny N,  Calman K editor. Oxford textbook of palliative medicine. New York: Oxford University Press; 2003;p. 438–458
  25. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci. 1999;19:10886–10897
  26. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205–218
  27. Shimoyama M, Tanaka K, Hasue F, Shimoyama N. A mouse model of neuropathic cancer pain. Pain. 2002;99:167–174
  28. Sommer C, Myers RR. Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush. Acta Neuropathol. 1995;90:478–485
  29. Sweetnam PM, Wrathall JR, Neale JH. Localization of dynorphin gene product-immunoreactivity in neurons from spinal cord and dorsal root ganglia. Neuroscience. 1986;18:947–955
  30. Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, et al. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats. Pain. 1996;68:275–281
  31. Wacnik PW, Eikmeier LJ, Ruggles TR, Ramnaraine ML, Walcheck BK, Beitz AJ, et al. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci. 2001;21:9355–9366
  32. Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci. 2001;21:1779–1786
  33. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

PII: S0304-3959(04)00589-5

doi: 10.1016/j.pain.2004.12.018

PAIN
Volume 114, Issue 1 , Pages 221-230 , March 2005

Article Tools

* Image Usage & Resolution